Cathelicidin-BF-30 clinically approved as new drug

BF-30 is a single chain polypeptide which contains 30 amino acid residues, with a molecular mass of 3637. First isolated by CAS Institute of Zoology in Kunming which has specialized in antimicrobial peptides derived from snakes and amphibians, the peptide has been approved for clinical treatment of vaginosis but is also studied as an antiviral agent.

CAS news release, December 18, 2018


Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny